The life sciences industry has entered a new era for artificial intelligence (AI), one that has moved from the margins to the mainstream and expanded from traditional machine learning to autonomous AI agents.¹ Yet a persistent gap remains between what AI demonstrates in controlled environments and what it delivers at enterprise scale. Its gains are not consistently realized across settings or at scale. The challenge is making it work reliably, across global operations, within the rigorous constraints of a regulated environment. Nowhere is this challenge more visible than in regulatory intelligence.

The complexity inflection point

Regulatory intelligence has historically been defined by monitoring: tracking new and revised guidance, standards, and regulations as they emerged. Today, that definition is not enough.

A new or changed regulation or reference document is published somewhere in the world every 13 minutes.² Drug development timelines are compressing while therapeutic modalities grow more complex. Regulatory affairs teams must not only know what has changed, but also understand what it means, where it matters, and how it influences submissions and strategies. Manual review and research methods cannot keep pace with this volume and complexity, leading to a growing gap between the pace of regulatory change and the speed of organizational response.

Not all AI is built for regulated environments

General-purpose AI supports document extraction, summarization, and question answering. These capabilities reduce manual effort and improve access to information; however, in regulated environments, domain knowledge is especially critical for optimizing value. For example, a language model drafting a clinical study synopsis needs to understand not just prose but the expectations of ICH E3, the requirements of the target health authority, and the therapeutic conventions. This is knowledge that cannot be injected through a prompt template. It must be embedded in the architecture itself—in the data assets, the reasoning frameworks, and the guardrails.

Domain-specialized systems go further: they are purpose-built to consult multiple regulatory knowledge sources in parallel, cross-check answers across databases, preserve the conditional language that defines regulatory text, and cite every fact back to its origin so that users can verify and defend the response. These capabilities compress hours of manual cross-database research into seconds, and because every claim is cited and every gap disclosed, the answers can be defended, not just consumed.

What even domain-specialized systems do not yet do, however, is operate autonomously over time by continuously monitoring regulatory change, assessing relevance as conditions evolve, and coordinating multi-step workflows without manual orchestration. That is the threshold agentic AI is designed to cross.

Agentic AI: Aligning technology to regulatory reality

Agentic AI marks a departure from conventional approaches in that it is designed to pursue objectives rather than respond to prompts. Instead of executing one task at a time, an agentic system plans, coordinates, and executes multiple steps over time, mirroring how regulatory work actually occurs.

In regulatory intelligence, this could take the form of specialized agents working in concert. For example:

• One agent continuously monitors regulatory sources and detects changes.
• Another agent classifies relevance by region, therapeutic area, or product.
• A third agent assesses impact and maps changes to the affected documents.
• An orchestrator agent coordinates the workflow and escalates insights to regulatory experts.

The specific configuration varies by use case, but the principle is consistent: each agent operates within a bounded scope, and human oversight governs the points where regulatory judgment is required.

Trust as an architectural principle

For regulatory intelligence to be used with confidence, trust is a prerequisite. When a regulatory affairs team relies on an AI-generated impact assessment affecting patient access across multiple markets, the system's reasoning must be transparent and fully auditable. This is not only to satisfy regulatory expectations. It is to enable sponsors to confidently defend their strategic and evidentiary decisions.

Agentic AI architectures must capture every interaction and inference in a structured audit trail that can be reviewed forensically. Purpose-built guardrails must operate at the infrastructure level, not as a post-hoc filter, but as a constraint embedded in the agent's operating logic, ensuring every agent remains within strictly defined scientific and regulatory boundaries. Transparency, auditability, domain-embedded guardrails, and experts-in-the-loop are all requirements that distinguish Healthcare-grade AI®: AI engineered to meet the level of precision, trust, and governance that life sciences demand.

Acknowledging the tradeoffs

Agentic AI is not a shortcut, however. It introduces architectural complexity, requires thoughtful governance, and demands close alignment with regulatory operating models. Designing bounded autonomy, escalation paths, and human-in-the-loop controls takes effort.

Regulatory intelligence is complex enough to justify that investment. When implemented responsibly, agentic AI systems respect regulatory complexity, embed domain context, and earn trust through transparency.

The road ahead

The next chapter of regulatory intelligence will not be defined by faster alerts or better summaries, but by systems that continuously translate regulatory change into decision ready insights for regulatory professionals, with trust built in by design. IQVIA.ai³ delivers this capability through a unified, agentic AI platform purpose built for life sciences — combining Healthcare-grade AI®, the deepest healthcare data assets with domain expertise spanning clinical and commercial operations, real-world evidence, and end to end auditability to help organizations scale regulatory intelligence without compromising rigor.

References

1. IQVIA, "Human-at-the-Helm: Turning Agentic AI into a Strategic Advantage for Global Regulatory Affairs," Blog, April 2026. Available: https://www.iqvia.com/blogs/2026/04/human-at-the-helm-turning-agentic-ai-into-a-strategic-advantage-for-global-regulatory-affairs
2. IQVIA Regulatory Intelligence data. Cited in IQVIA, "The Impact of Generative AI in Quality Management," White Paper, June 2024.
3. IQVIA, "IQVIA.ai Platform," [Online]. Available: https://www.iqvia.com/solutions/innovative-models/artificial-intelligence-and-machine-learning/iqvia-ai-platform. Accessed May 2026.